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The neoplasms of the salivary glands account for 2% of head and neck tumors and the most common
form is the Pleomorphic adenoma (PA). Parotid gland is affected from 80% to 90% of cases. In elderly these
tumors occur mostly in females. These benign tumors are composed of epithelial and myoepithelial cells
that are arranged with various morphological patterns and subtypes. The classiﬁcation of these tumors is
also based on the amount and nature of the stroma. In literature there is an almost complete consensus
that, in the major salivary glands, PAs are enclosed by a layer of ﬁbrous tissue often called “capsule” but
there is disagreement about the form, extension and thickness of this layer. The treatment is surgical and
there are two main different surgical approaches: an enucleation (local dissection) or so-called subtotal
superﬁcial parotidectomy and lateral or superﬁcial total parotidectomy. Histopathological characteristics
of PAs especially of capsular alterations such as thin capsule areas, capsule-free regions, capsule pene-
tration, satellite nodules and pseudopodia in the different subtypes are important for the choice of
surgical treatment and the ﬁrst explanation for tumor recurrence. In our study we describe a morpho-
logical features of 84 cases of pleomorphic adenoma of parotid gland from elderly patients treated by a
surgical “enucleation like” method called nucleoresection.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Parotid gland tumors represent 2e3% of head and neck tumors
and 0.6% of all tumors in the body. Parotid pleomorphic adenoma is
the most common slow-growing benign neoplasm of the salivary
glands. It constitute approximately 70e80% of benign parotid glandd Health Sciences, University
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by Elsevier Ltd. All rights reservedtumors [1e5]. Sometimes these tumors could be misdiagnosed
with other lateral-pharyngeal regionmasses [6,7]. Usually occurs in
peoples of all ages, and the highest incidence is in the fourth to
sixth decades [1]. In old age it occurs more frequently in males than
in females patients [1,2]. These tumors are most often diagnosed
and treated when the tumor is small (<4 cm), mobile, and located
in superﬁcial lobe [8e10]. The parotid gland is divided into super-
ﬁcial and deep lobes by virtue of the facial nerve, which passes
trough its substance [9,10]. The “superﬁcial lobe” include the pa-
renchyma's part of the gland lies lateral to the nerve. Approxi-
mately 90% of parotid tumors occur in this part of the gland. The
remaining 10% occur in the “deep lobe” the lower part of the gland
lying deep to the facial nerve [9]. These benign mixed tumors are
characterized by cellular polymorphism and composed of an
epithelial and myoepithelial cells and connective tissue component.
Table 1
In this table are reported measures of capsule thickness and their relationship
with tumor grading.
Grading Capsule thickness
Tipo I (>8 mm < 25 mm) 215.6 mm
Tipo I (>25 mm) 211.8 mm
Tipo II (>8 mm < 25 mm) 221.3 mm
Tipo II (>25 mm) 219.7 mm
Tipo III (>8 mm < 25 mm) 255.5 mm
Tipo III (>25 mm) 223.6 mm
Tipo IV (>8 mm < 25 mm) 229.6 mm
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origin [11e15]. Macroscopically it has surrounding “capsule” from
which it can be enucleated-often the treatment used in the past.
Often these tumors do not have a true capsule but can press sur-
rounding normal salivary gland, frequently having ﬁnger-like ex-
tensions into the normal tissues [16]. These and others
histopathological characteristics are the main explanation for tu-
mor recurrence after inappropriate surgical treatment. The
instrumental examination used for planning the surgical treatment
to be applied and for studying the relations of recurrence with
glandular parenchyma were CT with contrast medium or MR of
head and neck. In this context, the value of morphological ﬁndings
obtained by ﬁne needle aspiration cytology (FNAC) can be ques-
tioned [17e26]. Surgical management of pleomorphic adenoma 50
years ago consisted predominantly of local excision or “enucleation
technique”, a procedure that yields recurrence rates from 20% to
45%. The hypothesis for recurrence of pleomorphic adenoma using
this type of surgical approach is that microscopic portions of tumor
perforate the capsule and are shared off resulting in a subtotal
removal [27,28]. Nevertheless, some complications can be occurred
during surgical procedure. The main complication is temporary/
permanent facial nerve paralysis that compromises quality of life.
Various studies showed a positive relationship between the extent
of parotid surgery and postoperative facial nerve function. Another
relatively frequent complication is Frey syndrome/gustatory
sweating. A further unwanted complication of surgical approaches
in recurrent tumors is parotid cancer development. In literature
patients treated by different surgical procedures showed in
different percentages these dysfunctions [29e34]. The replacement
of simple enucleation of tumor with other surgical approaches like:
superﬁcial parotidectomy (SP), total parotidectomy (TP), and
extracapsular dissection (ECD) as treatment of choice reduced
dramatically the incidence of tumor's recurrence and complications
[35e37]. There is no hint of a remodeling of Ca2þ toolkit, that has
been observed in other tumoral lesions, including renal cellular
carcinoma [38e40], and prostate cancer [41], mieloﬁbrosis [42],
and used as target for selective molecular therapies. Actually there
is a general consensus about relevance of adenoma “capsule”; in
this paper we measured its thickness and try to demonstrate the
precise relationship between this histopathologic feature, surgical
management and tumor recurrence.
2. Material and methods
Samples of PA affecting the major salivary gland from 84 pa-
tients were collected between 2002 and 2011. Patients with
recurrent PA or history of any other parotid gland surgery were
excluded from the study. According to epidemiologic data of elderly
54 patients were females (64.2%) and only 30 were males (35.7%).
Mean age was 67.5 years ± 4.9 years SD. In 76 of 84 cases (90.4%)
ﬁrst diagnosis was performed, while in 8 cases (9.5%) recurrence
occurred. All patients underwent ear, nose and throat (ENT)
specialist examination, ultrasonography and preoperative ﬁne-
needle aspiration biopsy at Otolaryngology Department of Second
University of Naples. A Nucleoresection surgical approach was
performed in 76 patients (90.4%). In 3 patients (3.5%) and in 5 pa-
tients (5.9%) superﬁcial parotidectomy and total parotidectomy
respectively were used to remove the masses. After surgical pro-
cedures, specimens were ﬁxed in 4% paraformaldehyde. Before
dissecting the specimens for histopathological processing the sur-
face of the parotid gland, which usually was protruded by the ad-
enomas was inked with a speciﬁc color. We used India Ink color so
it is feasible that minor capsular artifacts arose during ﬁxation and
cutting so the degree of invasion or capsular damage might have
been underestimated. The inked specimens were dipped into Bouinsolution for 30 s to mordant the ink to the surface, thus minimizing
smearing during dissection. The specimens were cut into a various
number of slices of 4-mm thickness according to the tumor size.
Slices were perpendicular to the long axis of the tumor nodule,
which usually correspond to the long axis of the gland. The tip of
the small tumor poles were cut perpendicular to the main slicing
direction to obtainmany transverse cuts of the tumor capsule of the
poles. Thus, the slides were dehydrated in a graded series of alco-
hols and xylene and embedded in parafﬁn. Sections of 5-mm
thickness were stained with Emaoxilin & Eosin. A Leitz Axiophot
microscope (Leitz, Germany) equipped for microphotography was
used for light microscopic observations. An advanced software for
the analysis of images (Quantimet 520, Leica, Germany) was used to
measure some characteristics of sections. Images were directly
acquired by optic microscope at 20 enlargement using a special-
ized video camera (DC 200, Leica, Germany). The histologic exam-
ined areas were digitized and successively processed. The optic
quality of these areas was optimized by modifying the brilliance
and the contrast. The stained areas were highlighted by the pro-
gram on the basis of their levels of gray and measured. This mea-
surement was realized on 5 sections for each sample and six ﬁelds
were analyzed per section. The mean value of measurement
derived by the analysis of all areas in the 5 sections was reported.
Sections were examined and measured by three independent
observers.3. Results
In our series, cytological study had an excellent diagnostic value
with a higher sensitivity in comparisonwithMRI scan. According to
Seifert et al. original classiﬁcation partially revised by Stennert
et al., in 2001 our samples were graded in four types [11,12]. Type I
comprised 13 patients (15.4%), type II comprised 44 patients
(52.4%), type III included 18 subjects (21.4%) and ﬁnally 9 patients
(10.7%) were assigned to type IV. Results of capsule measurement
performed using analysis of images software are summarized in
Table 1. Parenchyma-rich tumors showed a ticker capsule than in
stroma-rich tumors. In our samples hypercellular PAs have a thick
capsule (Fig. 1(A) and (B)). Hypocellular tumors have a thin capsule
and constitute the most frequently encountered histological type in
recurrence (Fig. 1(C) and (D)). In stroma rich tumors the largest
amount of stromal differentiation were represented by myxoma-
tous tissue followed by chondroid and mixed mucochondroid
stroma. According to literature tumors of deep lobe have a thicker
capsule than those located in the superﬁcial lobe. Tumors pseu-
dopodias or grow through capsular breaches to extend to adjacent
parotid or adipose or other soft tissues. Pseudopodias or capsule
bulges are considered as an additional factor in recurrence. Capsule
dimensions and integrity represented a good tool to establish the
better surgical technique. We used in 76 patients (90.4%) a surgical
approach called nucleoresection (Fig. 2). In 3 patients (3.5%) and in
5 patients (5.9%) superﬁcial parotidectomy and total parotidectomy
Fig. 1. Morphological features of capsule: hypercellular PA showing a thick capsule (A); hypercellular PA with a thick capsule marked using India Ink (B); hypercellular PA showing a
thick capsule and a mixomatous stroma (C); hypercellular PA with a thick capsule and mixomatous and chondroid stromal tissue (Ematoxilin & Eosin stain. Original
magniﬁcation 150).
Fig. 2. Nucleoresection surgical technique (A and B: two different times of surgical procedure).
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of 24 months no local recurrences have been described and no
patients presented local complications in 76 patients undergone to
surgery at ﬁrst time. In 8 patients surgically treated for tumor
recurrence using superﬁcial (3 patients) or total parotidectomy (5
patients) complications occurred. After superﬁcial parotidectomy
one patient showed a Frey Syndrome while one patient treated
with total parotidectomy showed a facial nerve branches little
dysfunction.
4. Discussion
Aging is accompanied by a decline in the healthy function of
several organs in response to different mechanisms like oxidative
stress [43e45]. PA is a slowly growing, usually demarcated, and
mobile tumor occurring frequently in females elderly patients. It
constitute approximately 40e60% of benign salivary gland tumors
located in the superﬁcial parotid gland lobe in about 80% of cases
[1e5,46]. This benign tumor is characterized by 3 main morpho-
logical features. The capsule is the most relevant structural com-
ponents of PA. The other two morphological features areparenchyma (tumor epithelial cells) and stroma [11e15,47]. The
parenchymal/stromal ratio varies, and was used to classify these
tumors in four types. Many Authors have been recognized
parenchyma-rich and stroma-rich variants [11e15]. There is no
consensus whether the capsule is newly formed structure or re-
ﬂects pre-existing connective tissue compressed by the growing
tumor. Morphologically, the capsule could be consist as thick,
dense, ﬁbrous tissue that may be discontinuous or absent or
become invaded and even penetrated by a tumor. Correlation be-
tween capsular features and parenchymal/stromal ratio or the
location of the tumor has been made. The capsule is usually
0.015e1.75-mm thick and it is thicker in parenchyma-rich tumors
than in stroma-rich tumors. In our series of cases hypercellular PAs
have a thick capsule while hypocellular tumors have a thin capsule
and constitute the most frequently encountered histological type in
recurrence [48e50]. Half to two thirds of stroma rich tumors show
a variable/focal absence of the capsule. Tumors pseudopodias or
bulge or grow through capsular breaches to extend to adjacent
parotid or soft tissues. Where the capsule is absent, tumor invades
adjacent parotid or adipose tissue either as a broad advancing front
or as small mammillations bulging out from the main mass
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consideration of the so-called tumor satellites [51]. In particular
satellites could correspond with section proﬁles of extracapsular
tumor extension; continuity with the main mass is outside of the
plane of that section. These may be alternatively attributed to the
multifocal/multicentric origin of PAs [51]. The instrumental exam-
ination used for diagnosis and to plan the best were CT with
contrast medium or MR of head and neck. There is no general
consensus about ﬁne needle aspiration cytology (FNAC) which
morphological ﬁndings could be useful to surgical treatment
[17e26]. Almost all PAs can be effectively treated by surgical pro-
cedures. PAs, small, mobile, with a clearly observed capsule located
in the superﬁcial lobe/tail of the parotid gland can be removed by
limited surgery with few complications. Some complications can be
occurred during surgical procedure. The main complications are:
temporary/permanent facial nerve, Frey syndrome/gustatory
sweating and parotid cancer development. Patients treated by
different surgical procedures can be affected by these dysfunctions.
Superﬁcial parotidectomy (SP), total parotidectomy (TP), and
extracapsular dissection (ECD) replaced enucleation surgical tech-
nique [52e54]. Alternative really novel therapeutic approachmight
consist in injecting the patients with autologous endothelial pro-
genitor cells, to accelerate tissue revascularization and prevent a
surgical approach [55e59]. We used in our series of cases nucle-
oresection technique as surgical treatment of choice to reduce
dramatically the incidence of tumor's recurrence and complica-
tions. Nucleoresection is an “enucleation like” minimal margin
surgery utilizing a capsule margins as plane of dissection. In this
technique, the removal of healthy parotid tissue compared with
formal parotidectomy is limited, thus minimizing recurrence rate
and complications such as facial nerve dysfunction and Frey syn-
drome. Our results suggest that nucleoresection surgical approach
using capsule characteristics and other morphological features
could be considered a suitable option for ﬁrst time diagnosed pa-
tients, reducing signiﬁcantly tumor recurrence and complications
development. Nevertheless we need longer follow-up to draw
conclusive results.
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